
Trumab Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Trastuzumab (440mg)
Overview Trumab Injection
Herceptin-like injections are indicated for treating breast and gastric cancers. Their mechanism involves targeting and eliminating cancerous cells by suppressing HER2, the human epidermal growth factor receptor 2 protein. Administration is via injection by a healthcare professional. Dosage and frequency are determined by your physician, tailored to your condition and subject to adjustment. Adhere strictly to your prescribed regimen; improper usage or overdose may result in severe adverse reactions. Therapeutic effects might not be immediately apparent, potentially taking weeks or months; discontinue only under medical guidance. Common side effects include nausea, headache, skin rash, sleep disturbances, and increased infection risk. This medication can reduce blood cell counts (both red and white), leading to heightened infection vulnerability. Regular blood tests are essential to monitor blood cell levels, alongside heart, liver function, and uric acid levels. Report shortness of breath, cough, chills, or limb swelling immediately. Inform your healthcare provider of all medications you're taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment to prevent conception.
Uses of Trumab Injection
Cancers affecting the breast and stomach
Major Benefits of Trumab Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Trumab Injection:
- Anemia (low number of red blood cells)
- Chills
- Common cold
- Cough
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
- Fatigue
- Fever
- Headache
- Heart failure
- Infection
- Insomnia (difficulty in sleeping)
- Mucosal inflammation
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Taste change
- Upper respiratory tract infection
- Weight loss
How to use Trumab Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Trumab Injection works:
The monoclonal antibody Trumab, a recombinant IgG1 formulation, targets HER2, the human epidermal growth factor receptor 2 protein. By binding to HER2, it prevents the uncontrolled growth of breast and gastric cancer cells. This action directly eliminates cancer cells while also disrupting multiple downstream signaling pathways crucial for tumor development.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Trumab Injection and alcohol may result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Trumab Injection during pregnancy is contraindicated due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Trumab Injection while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Trumab Injection on driving ability is undetermined. Refrain from operating a vehicle if you develop symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Trumab Injection in individuals with kidney impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary for this population. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data on Trumab Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Trumab Injection :
Should you forget a Trumab Injection, seek your physician's advice.
Facts to Know About Trumab Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Drugs |
| Actions | Monoclonal antibody HER2/neu (ErbB2) inhibitor |
